Antigenix Therapeutics
Antigenix Therapeutics is a startup headquartered in Princeton, United States, founded in 2024. It has raised at least $3.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Antigenix Therapeutics has raised at least $3.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Antigenix Therapeutics sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in Princeton
- Aruka Bio
- Evermore Technologies
- Neurock Pharmaceuticals
- Populus Media
- Rhodenergy An Environmental Co
- Ricovr Healthcare
- Ventis Medical
Related
- Innovation profile of Princeton
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Antigenix Therapeutics do?
Antigenix Therapeutics is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Antigenix Therapeutics raised?
At least $3.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Antigenix Therapeutics based?
Antigenix Therapeutics is headquartered in Princeton, United States.
When was Antigenix Therapeutics founded?
Antigenix Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.